A randomised trial comparing 8 cycles of CPT11 [irinotecan] with CPT11 until disease progression in patients with colorectal cancer resistant to 5-fluorouracil (5FU).
Phase of Trial: Phase IV
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 06 Aug 2009 Actual end date (31 Dec 2005) added as reported by ISRCTN: Current Controlled Trials.
- 16 Feb 2006 New trial record.